Chemotherapy is one of the most common (but powerful and often debilitating) treatments to combat several types of cancer. Thankfully, many patients survive as a result of this drug but thousands are left with chronic pain as a long-term side effect.

A new report states that a third of all cancer survivors experience long-term post-treatment pain after undergoing chemo:

CIPN_INFO Graphic

Calmare Pain Therapy Treatment received its initial FDA clearance as a treatment specifically for chemotherapy-induced peripheral neuropathy, or CIPN.

Here’s an account of a Calmare patient who came to us here in New Jersey from Europe to treat her ongoing post-chemo neuropathy.

Mayo Clinic has been engaged in Calmare scrambler clinical trials for the past two years. The Massey Cancer Center at VCU has also been engaged in fruitful research.

You can find another clinical trial/research performed by doctors and researchers at the Paul Carbone Cancer Center at the University of Wisconsin here https://calmaretherapynj.com/clinical-trials-2/u-of-wisconsin-madison-cipn/

Teaching hospitals using Calmare Therapy

The device is currently being used in the U.S. at these key teaching hospitals:

  • Virginia Commonwealth University’s Massey Cancer Center
  • Paul Carbone Cancer Center at University of Wisconsin-Madison

We talk with patients and families every day about pain

If you or a loved one is dealing with pain after chemotherapy treatment, you know how difficult it can be. Dr. Michael Cooney talks with patients and families every day about if / how Calmare scrambler therapy treatment may help lessen or even alleviate CIPN. Feel free to reach out to the Calmare NJ team.

Advertisements